BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37013263)

  • 1. The correlation between women's various gynaecological diseases to ovarian cancer in Sulaimaniyah City, Iraq.
    Karim SMH; Fattah CN
    J Int Med Res; 2023 Apr; 51(4):3000605231158949. PubMed ID: 37013263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of benign gynaecological diseases and risk of endometrial and ovarian cancers.
    Shen F; Liu Y; Lin L; Zhao M; Chen Q
    J Cancer; 2020; 11(11):3186-3191. PubMed ID: 32231723
    [No Abstract]   [Full Text] [Related]  

  • 3. The Risks for Ovarian, Endometrial, Breast, Colorectal, and Other Cancers in Women With Newly Diagnosed Endometriosis or Adenomyosis: A Population-Based Study.
    Kok VC; Tsai HJ; Su CF; Lee CK
    Int J Gynecol Cancer; 2015 Jul; 25(6):968-76. PubMed ID: 25893280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in anti-müllerian hormone levels as a biomarker for ovarian reserve after ultrasound-guided high-intensity focused ultrasound treatment of adenomyosis and uterine fibroid.
    Lee JS; Hong GY; Lee KH; Kim TE
    BJOG; 2017 Aug; 124 Suppl 3():18-22. PubMed ID: 28856867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary chorionic gonadotropin subunits and beta-core in nonpregnant women. A study of benign and malignant gynecologic disorders.
    Neven P; Iles RK; Lee CL; Hudson CN; Shepherd JH; Chard T
    Cancer; 1993 Jun; 71(12):4124-30. PubMed ID: 7685240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profibrotic interleukin-33 is correlated with uterine leiomyoma tumour burden.
    Santulli P; Even M; Chouzenoux S; Millischer AE; Borghese B; de Ziegler D; Batteux F; Chapron C
    Hum Reprod; 2013 Aug; 28(8):2126-33. PubMed ID: 23739220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gynaecological pathologies leading to emergency department admissions: A cross-sectional study.
    Xholli A; Londero AP; Camacho Mattos L; Vujosevic S; Cagnacci A
    Eur J Obstet Gynecol Reprod Biol; 2023 Mar; 282():38-42. PubMed ID: 36630817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of the National Cancer Institute and the Eunice Kennedy Shriver National Institute of Child Health and Human Development-sponsored workshop: gynecology and women's health-benign conditions and cancer.
    Samimi G; Sathyamoorthy N; Tingen CM; Mazloomdoost D; Conroy J; Heckman-Stoddard B; Halvorson LM
    Am J Obstet Gynecol; 2020 Dec; 223(6):796-808. PubMed ID: 32835714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant risk of pelvic mass after hysterectomy for adenomyosis or endometriosis.
    Chao X; Liu Y; Ji M; Wang S; Shi H; Fan Q; Lang J
    Medicine (Baltimore); 2020 Apr; 99(15):e19712. PubMed ID: 32282727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptive use and benign gynecologic conditions. A review.
    Chiaffarino F; Parazzini F; La Vecchia C; Ricci E; Crosignani PG
    Contraception; 1998 Jan; 57(1):11-8. PubMed ID: 9554245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometriosis, leiomyoma and adenomyosis: the risk of gynecologic malignancy.
    Verit FF; Yucel O
    Asian Pac J Cancer Prev; 2013; 14(10):5589-97. PubMed ID: 24289548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of human adenomyosis.
    Hever A; Roth RB; Hevezi PA; Lee J; Willhite D; White EC; Marin EM; Herrera R; Acosta HM; Acosta AJ; Zlotnik A
    Mol Hum Reprod; 2006 Dec; 12(12):737-48. PubMed ID: 17020905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the sensitivity and specificity of serum level of prostasin, CA125, LDH, AFP, and hCG+β in epithelial ovarian cancer patients.
    Bastani A; Asghary A; Heidari MH; Karimi-Busheri F
    Eur J Gynaecol Oncol; 2017; 38(3):418-424. PubMed ID: 29693884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound findings in infertile women with endometriosis: evidence of concomitant uterine disorders.
    Capezzuoli T; Vannuccini S; Fantappiè G; Orlandi G; Rizzello F; Coccia ME; Petraglia F
    Gynecol Endocrinol; 2020 Sep; 36(9):808-812. PubMed ID: 32133885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases.
    Molina R; Escudero JM; Augé JM; Filella X; Foj L; Torné A; Lejarcegui J; Pahisa J
    Tumour Biol; 2011 Dec; 32(6):1087-95. PubMed ID: 21863264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The occurrence of endometriosis with ovarian carcinomas is not purely coincidental.
    Qiu L; Wang S; Lang JH; Shen K; Huang HF; Pan LY; Wu M; Yang JX
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):225-8. PubMed ID: 23866908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for adenomyosis in patients with symptomatic uterine leiomyomas.
    Romanek K; Bartuzi A; Bogusiewicz M; Rechberger T
    Ginekol Pol; 2010 Sep; 81(9):678-80. PubMed ID: 20968175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial nerve fibers in women with endometriosis, adenomyosis, and uterine fibroids.
    Zhang X; Lu B; Huang X; Xu H; Zhou C; Lin J
    Fertil Steril; 2009 Nov; 92(5):1799-801. PubMed ID: 19535047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenomyosis pathogenesis: insights from next-generation sequencing.
    Bulun SE; Yildiz S; Adli M; Wei JJ
    Hum Reprod Update; 2021 Oct; 27(6):1086-1097. PubMed ID: 34131719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of human chorionic gonadotropin-related immunoreactivity in serum, ascites and tumour cysts of patients with gynaecologic malignancies.
    Grossmann M; Hoermann R; Gocze PM; Ott M; Berger P; Mann K
    Eur J Clin Invest; 1995 Nov; 25(11):867-73. PubMed ID: 8582453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.